Physician profile
Daniel A Eisenberg
NPI 1770670515
$1,213.17
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $173 · 2021: $19.60 · 2022: $287 · 2024: $63.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $234.54 | 2022 | |
| Amgen INC. | $179.70 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.97 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $66.71 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $65.01 | 2019 | |
| Pfizer INC. | $63.38 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $56.33 | 2019-2020 | |
| Braemar Manufacturing, LLC | $55.52 | 2019 | |
| Medtronic, INC. | $47.36 | 2021-2022 | |
| Abbott Laboratories | $45.41 | 2020-2024 | Aveir |
| Lsi Solutions INC | $38.55 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $35.81 | 2019 | |
| Edwards Lifesciences Corporation | $29.47 | 2019 | |
| Akcea Therapeutics, INC. | $26.38 | 2020 | |
| Amarin Pharma, INC. | $22.62 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.83 | 2019 | |
| Irhythm Technologies, INC. | $21.08 | 2024 | Zio Monitor, Zio Xt Patch |
| Vertiflex, INC. | $19.36 | 2019 | |
| Boston Scientific Corporation | $17.84 | 2024 | Emblem Mri S-Icd |
| Astellas Pharma US INC | $17.25 | 2019 | |
| Medtronic Vascular, INC. | $14.52 | 2020 | |
| Getinge USA Sales, LLC | $12.18 | 2019 | |
| Biomerieux INC | $10.35 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.